The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses.

INTRODUCTION: The ReIMAGINE Consortium was conceived to develop risk-stratification models that might incorporate the full range of novel prostate cancer (PCa) diagnostics (both commercial and academic). METHODS: ReIMAGINE Risk is an ethics approved (19/LO/1128) multicentre, prospective, observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsden, Teresa, McCartan, Neil, Brown, Louise, Rodriguez-Justo, Manuel, Syer, Tom, Brembilla, Giorgio, Van Hemelrijck, Mieke, Coolen, Ton, Attard, Gerhardt, Punwani, Shonit, Moore, Caroline M., Ahmed, Hashim U., Emberton, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870538/
https://www.ncbi.nlm.nih.gov/pubmed/35202397
http://dx.doi.org/10.1371/journal.pone.0259672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870538/
https://www.ncbi.nlm.nih.gov/pubmed/35202397
http://dx.doi.org/10.1371/journal.pone.0259672

Ejemplares similares